| Year |
Citation |
Score |
| 2023 |
Snyder KM, Dixon KJ, Davis Z, Hosking M, Hart G, Khaw M, Matson A, Bjordahl R, Hancock B, Shirinbak S, Miller JS, Valamehr B, Wu J, Walcheck B. iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. Journal For Immunotherapy of Cancer. 11. PMID 38056893 DOI: 10.1136/jitc-2023-007280 |
0.349 |
|
| 2023 |
Bjorgen JC, Dick JK, Cromarty R, Hart GT, Rhein J. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics? Frontiers in Immunology. 14: 1267774. PMID 37928543 DOI: 10.3389/fimmu.2023.1267774 |
0.427 |
|
| 2023 |
Dahlvang JD, Dick JK, Sangala JA, Kennedy PR, Pomeroy EJ, Snyder KM, Moushon JM, Thefaine CE, Wu J, Hamilton SE, Felices M, Miller JS, Walcheck B, Webber BR, Moriarity BS, ... Hart GT, et al. Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. Journal of Immunology (Baltimore, Md. : 1950). PMID 36881874 DOI: 10.4049/jimmunol.2200488 |
0.607 |
|
| 2022 |
Dick JK, Hart GT. Natural Killer Cell Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Against Plasmodium falciparum-Infected Red Blood Cells. Methods in Molecular Biology (Clifton, N.J.). 2470: 641-657. PMID 35881380 DOI: 10.1007/978-1-0716-2189-9_48 |
0.425 |
|
| 2021 |
Hintz HM, Snyder KM, Wu J, Hullsiek R, Dahlvang JD, Hart GT, Walcheck B, LeBeau AM. Simultaneous engagement of tumor and stroma targeting antibodies by engineered NK-92 cells expressing CD64 controls prostate cancer growth. Cancer Immunology Research. PMID 34452926 DOI: 10.1158/2326-6066.CIR-21-0178 |
0.333 |
|
| 2020 |
Howe MK, Dowdell K, Kuehn HS, Li Q, Hart GT, Garabedian D, Liepshutz K, Hsu AP, Su H, Niemela JE, Stoddard JL, Uzel G, Shereck E, Schulz L, Feldman T, et al. Patients with NK cell chronic active EBV have immature NK cells and hyperactivation of PI3K/Akt/mTOR and STAT1 pathways. The Journal of Infectious Diseases. PMID 32386415 DOI: 10.1093/Infdis/Jiaa232 |
0.387 |
|
| 2020 |
Pampusch MS, Haran KP, Hart GT, Rakasz EG, Rendahl AK, Berger EA, Connick E, Skinner PJ. Rapid Transduction and Expansion of Transduced T Cells with Maintenance of Central Memory Populations. Molecular Therapy. Methods & Clinical Development. 16: 1-10. PMID 31673565 DOI: 10.1016/J.Omtm.2019.09.007 |
0.414 |
|
| 2019 |
Burrack KS, Hart GT, Hamilton SE. Contributions of natural killer cells to the immune response against Plasmodium. Malaria Journal. 18: 321. PMID 31533835 DOI: 10.1186/S12936-019-2953-1 |
0.676 |
|
| 2019 |
Tran TM, Guha R, Portugal S, Skinner J, Ongoiba A, Bhardwaj J, Jones M, Moebius J, Venepally P, Doumbo S, DeRiso EA, Li S, Vijayan K, Anzick SL, Hart GT, et al. A Molecular Signature in Blood Reveals a Role for p53 in Regulating Malaria-Induced Inflammation. Immunity. PMID 31492649 DOI: 10.1016/J.Immuni.2019.08.009 |
0.436 |
|
| 2019 |
Hart GT, Tran TM, Theorell J, Schlums H, Arora G, Rajagopalan S, Sangala ADJ, Welsh KJ, Traore B, Pierce SK, Crompton PD, Bryceson YT, Long EO. Adaptive NK cells in people exposed to correlate with protection from malaria. The Journal of Experimental Medicine. PMID 30979790 DOI: 10.1084/Jem.20181681 |
0.515 |
|
| 2018 |
Arora G, Hart GT, Manzella-Lapeira J, Doritchamou JY, Narum DL, Thomas LM, Brzostowski J, Rajagopalan S, Doumbo OK, Traore B, Miller LH, Pierce SK, Duffy PE, Crompton PD, Desai SA, et al. NK cells inhibit growth in red blood cells via antibody-dependent cellular cytotoxicity. Elife. 7. PMID 29943728 DOI: 10.7554/Elife.36806 |
0.466 |
|
| 2018 |
Burrack KS, Huggins MA, Taras E, Dougherty P, Henzler CM, Yang R, Alter S, Jeng EK, Wong HC, Felices M, Cichocki F, Miller JS, Hart GT, Johnson AJ, Jameson SC, et al. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells. Immunity. PMID 29625893 DOI: 10.1016/J.Immuni.2018.03.012 |
0.625 |
|
| 2018 |
Arora G, Hart GT, Manzella-Lapeira J, Doritchamou JY, Narum DL, Thomas LM, Brzostowski J, Rajagopalan S, Doumbo OK, Traore B, Miller LH, Pierce SK, Duffy PE, Crompton PD, Desai SA, et al. Author response: NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity Elife. DOI: 10.7554/Elife.36806.017 |
0.458 |
|
| 2016 |
Swanson PA, Hart GT, Russo MV, Nayak D, Yazew T, Peña M, Khan SM, Janse CJ, Pierce SK, McGavern DB. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. Plos Pathogens. 12: e1006022. PMID 27907215 DOI: 10.1371/Journal.Ppat.1006022 |
0.468 |
|
| 2016 |
Hart GT, Akkaya M, Chida AS, Wei C, Jenks SA, Tipton C, He C, Wendel BS, Skinner J, Arora G, Kayentao K, Ongoiba A, Doumbo O, Traore B, Narum DL, et al. The Regulation of Inherently Autoreactive VH4-34-Expressing B Cells in Individuals Living in a Malaria-Endemic Area of West Africa. Journal of Immunology (Baltimore, Md. : 1950). PMID 27798155 DOI: 10.4049/Jimmunol.1600491 |
0.425 |
|
| 2015 |
Gordon EB, Hart GT, Tran TM, Waisberg M, Akkaya M, Kim AS, Hamilton SE, Pena M, Yazew T, Qi CF, Lee CF, Lo YC, Miller LH, Powell JD, Pierce SK. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America. PMID 26438846 DOI: 10.1073/Pnas.1516544112 |
0.585 |
|
| 2015 |
Gordon EB, Hart GT, Tran TM, Waisberg M, Akkaya M, Skinner J, Zinöcker S, Pena M, Yazew T, Qi CF, Miller LH, Pierce SK. Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria. Mbio. 6. PMID 26037126 DOI: 10.1128/Mbio.00725-15 |
0.411 |
|
| 2015 |
Tran TM, Gordon EB, Hart GT, Waisberg M, Akkaya M, Kim A, Hamilton SE, Pena M, Yazew T, Qi C, Miller LH, Powell JD, Pierce SK. Novel Adjunctive Therapies for Cerebral Malaria That Target Metabolism Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1159 |
0.502 |
|
| 2014 |
Crompton PD, Moebius J, Portugal S, Waisberg M, Hart G, Garver LS, Miller LH, Barillas-Mury C, Pierce SK. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annual Review of Immunology. 32: 157-87. PMID 24655294 DOI: 10.1146/Annurev-Immunol-032713-120220 |
0.322 |
|
| 2012 |
Hart GT, Peery SL, Hamilton SE, Jameson SC. Cutting edge: Krűppel-like factor 2 is required for phenotypic maintenance but not development of B1 B cells. Journal of Immunology (Baltimore, Md. : 1950). 189: 3293-7. PMID 22942434 DOI: 10.4049/Jimmunol.1201439 |
0.656 |
|
| 2012 |
Hart GT, Hogquist KA, Jameson SC. Krüppel-like factors in lymphocyte biology. Journal of Immunology (Baltimore, Md. : 1950). 188: 521-6. PMID 22223851 DOI: 10.4049/Jimmunol.1101530 |
0.53 |
|
| 2011 |
Hart GT, Wang X, Hogquist KA, Jameson SC. Krüppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proceedings of the National Academy of Sciences of the United States of America. 108: 716-21. PMID 21187410 DOI: 10.1073/Pnas.1013168108 |
0.624 |
|
| 2011 |
Takada K, Wang X, Hart GT, Odumade OA, Weinreich MA, Hogquist KA, Jameson SC. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. Journal of Immunology (Baltimore, Md. : 1950). 186: 775-83. PMID 21160050 DOI: 10.4049/Jimmunol.1000094 |
0.629 |
|
| 2004 |
Hart GT, Shaffer DJ, Akilesh S, Brown AC, Moran L, Roopenian DC, Baker PJ. Quantitative gene expression profiling implicates genes for susceptibility and resistance to alveolar bone loss. Infection and Immunity. 72: 4471-9. PMID 15271905 DOI: 10.1128/Iai.72.8.4471-4479.2004 |
0.314 |
|
| Show low-probability matches. |